SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1391)3/3/2000 8:04:00 AM
From: KLH  Read Replies (1) | Respond to of 2344
 
Q4 and FYE results: biz.yahoo.com



To: Jibacoa who wrote (1391)3/3/2000 10:57:00 AM
From: RWReeves  Read Replies (2) | Respond to of 2344
 
Compared to the immunotherapeutics pipeline at IMMU, BIOM seems pretty fully priced. Let's not forget a few months ago we were bottom fishing around $2.50.

Suggest fans of Canadian and British immunotherapy might also like AXO on the Toronto and CLL (US ADRs). CLL has a very ice pipeline also but isn't cheap any longer either.

FWIW not a short or a pumper-been around these a LOOONG time.

RWR